Lyra Therapeutics Announces Material Definitive Agreement
Ticker: LYRA · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1327273
| Field | Detail |
|---|---|
| Company | Lyra Therapeutics, INC. (LYRA) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, equity-sale, other-events
TL;DR
Lyra Therapeutics signed a material definitive agreement on 6/26, expect news.
AI Summary
Lyra Therapeutics, Inc. announced on June 26, 2025, that it entered into a Material Definitive Agreement. The company also reported on unregistered sales of equity securities and other events. The filing was made on June 27, 2025.
Why It Matters
This filing indicates a significant new agreement for Lyra Therapeutics, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can introduce new risks and opportunities that may affect the company's stock price.
Key Players & Entities
- Lyra Therapeutics, Inc. (company) — Registrant
- June 26, 2025 (date) — Date of earliest event reported
- June 27, 2025 (date) — Filing date
FAQ
What is the nature of the Material Definitive Agreement entered into by Lyra Therapeutics?
The filing does not specify the details of the Material Definitive Agreement, only that one was entered into on June 26, 2025.
What type of equity securities were sold in the unregistered sale?
The filing mentions unregistered sales of equity securities but does not provide specific details about the type or amount.
Are there any other significant events reported in this 8-K filing?
Besides the Material Definitive Agreement and unregistered sales of equity securities, the filing also lists 'Other Events' and 'Financial Statements and Exhibits' as items of disclosure.
What is Lyra Therapeutics' fiscal year end?
Lyra Therapeutics' fiscal year ends on December 31.
What is Lyra Therapeutics' business address?
Lyra Therapeutics' business address is 480 Arsenal Way, Watertown, MA 02472.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding Lyra Therapeutics, Inc. (LYRA).